Today: 10 June 2026
Browse Category

NYSE:TGT 1 September 2025 - 21 November 2025

Thanksgiving 2025 Store Hours: Is Kroger Open? H‑E‑B Hours, Louisville Malls and Which Stores Are Closed

Thanksgiving 2025 Store Hours: Is Kroger Open? H‑E‑B Hours, Louisville Malls and Which Stores Are Closed

Kroger stores will open on Thanksgiving 2025 with reduced hours, closing by mid-afternoon; pharmacies remain closed. H-E-B will operate 6 a.m. to noon. Louisville malls and most national chains, including Walmart, Target, and Costco, will be closed. Meijer, Food Lion, Whole Foods, and several Albertsons stores will open but close early.
Target Stock Slips as Q3 2025 Sales Fall and New CEO Bets on AI, Price Cuts and $5 Billion Store Upgrade Plan

Target Stock Slips as Q3 2025 Sales Fall and New CEO Bets on AI, Price Cuts and $5 Billion Store Upgrade Plan

Target reported a 1.6% drop in Q3 revenue to $25.27 billion, with comparable sales down 2.7%. Adjusted EPS beat expectations at $1.78, but fell from last year. The company cut its profit outlook and announced a turnaround plan focused on price cuts, store upgrades, and new AI partnerships. Shares fell nearly 2% pre-market, extending a year of steep losses.
Target (TGT) Stock Today: Holiday Discounts, AI Shopping Push and Dividend Power Ahead of Q3 Earnings

Target (TGT) Stock Today: Holiday Discounts, AI Shopping Push and Dividend Power Ahead of Q3 Earnings

Target shares closed at $89.96 on Friday, down 41% over the past year and 33% year-to-date. The company pays a quarterly dividend of $1.14 per share, yielding just above 5%. Empower Advisory Group raised its stake in Target by 78% in Q2. Target reports Q3 earnings November 19, with investors watching holiday sales strategy and guidance.
Retail Shock: Target Slashes 1,800 Jobs — Is the Economy in Danger?

Target (TGT) Stock Forecast: November 2025 Holiday Strategy, Layoffs and 2026 Outlook

Target closed at $89.90 on November 14, 2025, with a market cap of $40.9 billion and a trailing P/E of 10.5. The stock is down 42% over the past year and offers a 5% dividend yield, marking 54 years of dividend growth. Target trades at a steep discount to its 10-year average P/E, but faces weak sales, management turnover, and recent layoffs ahead of its November 19 earnings report.
16 November 2025
McConnell’s Hemp Crackdown Collides With Retail THC Boom: Big Brands, 39 AGs, and Congress Face a ‘Hemp War’ (Nov. 6, 2025)

McConnell’s Hemp Crackdown Collides With Retail THC Boom: Big Brands, 39 AGs, and Congress Face a ‘Hemp War’ (Nov. 6, 2025)

The Consumer Brands Association, representing Coca‑Cola, Nestlé, and others, urged Congress to ban intoxicating hemp products in FY26 spending talks. Thirty-nine state attorneys general renewed calls to tighten hemp’s legal definition. The Senate previously removed a House-backed hemp ban from a key bill, but negotiations continue. Meanwhile, Circle K and Target are expanding hemp-THC beverage sales as states impose new restrictions.
Retail Shock: Target Slashes 1,800 Jobs — Is the Economy in Danger?

Retail Shock: Target Slashes 1,800 Jobs — Is the Economy in Danger?

Target will cut about 1,800 corporate jobs, including 1,000 layoffs, in late October 2025—its largest reduction in a decade. Incoming CEO Michael Fiddelke cited slow decision-making and excess management layers. Target stock is down 30% this year as sales slump and consumer boycotts hit the retailer. Analysts expect weak holiday sales and continued discounting across U.S. retail.
28 October 2025
Target Shocks Workers: 1,000 HQ Jobs Cut Before Christmas – Retail Giant’s Woes Deepen

Target Shocks Workers: 1,000 HQ Jobs Cut Before Christmas – Retail Giant’s Woes Deepen

Target will cut about 1,000 corporate jobs and eliminate 800 open roles, affecting roughly 8% of its headquarters staff. The move follows three straight quarters of sales declines and consumer backlash over inventory and diversity issues. Target shares hovered near five-year lows at $94 on Oct. 23, while Walmart stock hit record highs. Employees were told to work remotely next week as the company finalizes layoffs.
24 October 2025
Walmart’s AI Push Sends Stock Soaring – Is Target the Bargain Buy Now?

Walmart’s AI Push Sends Stock Soaring – Is Target the Bargain Buy Now?

Walmart shares hit record highs near $107 on Oct. 23 after launching a ChatGPT shopping integration, up 18% year-to-date. CEO Doug McMillon raised sales and earnings guidance on strong U.S. and online growth. Target stock fell to $94, down 35% in 2025, after weak sales and a CEO transition announcement. Analysts remain bullish on Walmart, while Target holds appeal mainly for its 4.8% dividend yield.
Investors Beware: 7 Stocks to Avoid on October 22, 2025 Amid Alarming Warnings

Investors Beware: 7 Stocks to Avoid on October 22, 2025 Amid Alarming Warnings

Netflix shares fell over 6% after missing earnings due to a Brazilian tax charge. Texas Instruments warned of weak demand, pushing its stock down 7.6% and dragging chipmakers lower. Target neared multi-year lows as sales dropped and its CEO resigned. The Buffett Indicator hit 219%, with top bankers warning of overvalued markets and possible correction.
Costco Stock Surges Amid Retail Gloom – Will $900+ Shares Keep Climbing?

Costco (COST) Stock Slides to ~$924: Analyst Takeaways and Competitor Comparison (Oct 16, 2025)

Costco shares fell 3.4% to $924 on Oct. 16 despite fiscal Q4 net sales rising 8% to $84.4 billion and net income reaching $2.61 billion, both above forecasts. Same-store sales excluding gas increased 6.4%, and membership fee revenue jumped 14% to $1.72 billion. Walmart and Target also declined, while BJ’s Wholesale was flat. Wall Street’s 12-month price target for Costco averages $1,054.
Retailers Quit Selling Xbox?! Target & Walmart Rumored to Ditch Xbox Stock

Retailers Quit Selling Xbox?! Target & Walmart Rumored to Ditch Xbox Stock

Target and Walmart employees report Xbox consoles and games are being removed from store shelves, leaving only PlayStation and Nintendo products. Costco confirmed it no longer carries Xbox consoles, citing a business decision. Microsoft says it still supports physical games, but retailers report plunging Xbox sales. Both Target and Walmart declined to comment on the changes.
Vercel’s AI Breakthrough: $300M Raise Propels Developer Platform to $9.3B Valuation

Vercel’s AI Breakthrough: $300M Raise Propels Developer Platform to $9.3B Valuation

Vercel raised $300 million in Series F funding, pushing its valuation to $9.3 billion. The round was co-led by Accel and Singapore’s GIC, with new investors including BlackRock and Khosla Ventures. A $300 million secondary tender for employees and early backers will close next month. Vercel’s user base doubled and revenue rose 82% year-on-year.
Labor Day 2025 Tech Blowout: Record-Low Gadget Prices and Can’t-Miss Deals

Labor Day 2025 Tech Blowout: Record-Low Gadget Prices and Can’t-Miss Deals

Major U.S. retailers including Amazon, Walmart, Best Buy, and Target are offering steep Labor Day discounts on electronics through September 1, 2025. Apple’s MacBook Air with M4 chip dropped to $799, and AirPods 4th-gen fell 30% to $90. TV deals include Samsung’s Frame series and a 65" Roku 4K TV for $498 at Walmart. Flagship smartphones and headphones are also seeing record-low prices.

Stock Market Today

  • Ondas Shares Slip Premarket After 2.7 Million-Share SEC Filing
    June 10, 2026, 5:37 AM EDT. Ondas Inc. shares fell 1.45% premarket to $9.51 following a June 9 SEC filing registering 2.7 million shares for resale tied to its $196.6 million acquisition of Israel's Omnisys Ltd. The filing signals no new capital raised but adds potential selling supply, pressuring the volatile defense-drone stock. Despite a 6.31% drop Tuesday, Ondas posted a 10-fold revenue increase to $50.1 million in Q1 and aims for $390 million revenue in 2026. CEO Eric Brock highlighted a $457 million backlog and strong order flow exceeding $110 million this quarter, underscoring growth in integrated defense tech and automation demand.

Latest articles

Micron Stock’s $1 Trillion AI Test Is Here as Traders Look to June 24

Micron Stock’s $1 Trillion AI Test Is Here as Traders Look to June 24

10 June 2026
Micron shares fell 1.5% to $935.89 as the AI-chip rally cooled, despite bullish analyst calls and price targets up to $1,625; investors await the June 24 earnings report to see if tight memory chip supply and AI demand can sustain the stock’s trillion-dollar valuation amid broader market jitters and shifting sentiment.
Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

Ondas Dips Premarket After 2.7 Million-Share Filing

10 June 2026
SoFi Technologies traded near $16.47 in early premarket, little changed as investors weighed its AI and digital asset product push against a risk-off market mood, with no fresh earnings news and inflation data looming that could impact rates, loan demand, and fintech valuations.
Ondas Dips Premarket After 2.7 Million-Share Filing

SoFi Stock Holds Ahead of Pre-Market Test as Wall Street Grows Defensive

10 June 2026
Rolls-Royce shares rebounded 1.5% in London after Tuesday’s 2.68% drop, as investors weighed fresh airline criticism over engine delays against the company’s reaffirmed 2026 profit and cash flow guidance; CEO Tufan Erginbilgic said Rolls had a “strong start to the year,” but risks remain if airline pressure leads to higher costs or slower cash conversion.
LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

10 June 2026
LVMH shares slipped 0.49% to €489.90 in Paris after a four-day rebound, as investors weighed RBC’s reiterated Buy rating with a €600 target against ongoing 2026 losses and a 24% year-to-date drop; all eyes now turn to July’s first-half results for signs of recovery in Fashion & Leather Goods and any relief from Middle East weakness.
Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

10 June 2026
Roche’s participation certificates climbed 1.07% to CHF 322.20 after announcing a $2.3 billion deal with Nurix Therapeutics for late-stage blood-cancer drug bexobrutideg, planned to enter Phase 3 trials this summer in CLL, as investors weigh the asset’s potential to offset losses from expiring patents and drive mid-single-digit sales growth in 2026.
Go toTop